In a study conducted by researchers from the University of Melbourne, it was revealed that children with a severe form of epilepsy should receive the flu vaccine to prevent the increased risk of a seizure, declining language, and motor skills, and even the risk of mortality brought on by the influenza infection. The researchers concluded that the safe administration of the seasonal influenza vaccine should be prioritized in people with SCN1A-positive Dravet syndrome.

Another study published in Neurology showed that 88% of 21 children with SCN1A-positive Dravet syndrome who had a confirmed flu infection had developed some brain problems due to repetitive flu infections.

In the present study, 75% of the children recovered, but death or long-term brain complications were diagnosed in 1 in 5 cases. University of Melbourne Professor, Dr. Ingrid Scheffer, stated that the findings of the study can help change clinical practice. She pointed out that identifying safe strategies and strongly encouraging influenza vaccination in children and adults with SCN1A-Dravet syndrome is critical. However, before administering the influenza vaccination, healthcare providers should review the child’s regular anti-seizure medications. They should ensure that a seizure management plan is in place.